These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 3733208

  • 21. The histocompatibility (HLA) antigen distribution in multiple sclerosis patients in Zimbabwe.
    Lowe RF, Moore HH, Briggs BR.
    Cent Afr J Med; 1980 Nov; 26(11):234-6. PubMed ID: 7471189
    [No Abstract] [Full Text] [Related]

  • 22. [Relation between HLA and oculopharyngeal muscular dystrophy--study of a large family].
    Xu WZ.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Dec; 18(6):326-9. PubMed ID: 3869922
    [No Abstract] [Full Text] [Related]

  • 23. HLA antigens in multiple sclerosis.
    Sachs JA.
    Proc R Soc Med; 1977 Dec; 70(12):869-71. PubMed ID: 341175
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Impaired HLA capping capacity of peripheral blood lymphocytes in Duchenne muscular dystrophy.
    Sensi A, Venturoli A, Traniello S, Lucci M, Vullo C, Conighi C, Mattiuz PL, Båricordi OR.
    J Med Genet; 1984 Jun; 21(3):182-5. PubMed ID: 6379180
    [Abstract] [Full Text] [Related]

  • 30. Antibody formation after myoblast transplantation in Duchenne-dystrophic patients, donor HLA compatible.
    Roy R, Tremblay JP, Huard J, Richards C, Malouin F, Bouchard JP.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):995-7. PubMed ID: 8442296
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Histocompatibility antigens in multiple sclerosis patients].
    Khondkarian OA, Tananov AT, Zavalishin IA, Nevskaia OM, Kut'ina RM.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981 Feb; 81(2):7-10. PubMed ID: 7234266
    [Abstract] [Full Text] [Related]

  • 34. HLA antigens and mitogen responsiveness in multiple sclerosis.
    Paty DW, Cousin HK, Stiller CR.
    Transplant Proc; 1977 Mar; 9(1 Suppl 1):187-9. PubMed ID: 300927
    [Abstract] [Full Text] [Related]

  • 35. Immunosuppressive therapy in Duchenne muscular dystrophy: considerations for myoblast transfer studies.
    Mendell JR.
    Adv Exp Med Biol; 1990 Mar; 280():287-95. PubMed ID: 2248150
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Investigative approach to the muscular dystrophies.
    Engel WK.
    Adv Neurol; 1977 Mar; 17():197-226. PubMed ID: 888736
    [No Abstract] [Full Text] [Related]

  • 39. Motor neuropathies and motor neuron disorders: association with antiglycolipid antibodies.
    Pestronk A, Li F.
    Adv Neurol; 1991 Mar; 56():427-32. PubMed ID: 1649544
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.